Fluoroethylnormemantine hydrochloride

For research use only. Not for therapeutic Use.

  • CAT Number: I027446
  • CAS Number: 1639210-25-5
  • Molecular Formula: C12H21ClFN
  • Molecular Weight: 233.75
  • Purity: ≥95%
Inquiry Now

Fluoroethylnormemantine hydrochloride, a derivative of Memantine, is an antagonist of the N-methyl-D-aspartate (NMDA) receptor. [18F]-Fluoroethylnormemantine hydrochloride can be used as a positron emission tomography (PET) tracer. Fluoroethylnormemantine hydrochloride exhibits anti-amnesic, neuroprotective, antidepressant-like and fear-attenuating effects[1][2][3].
Fluoroethylnormemantine (0.1-10 mg/kg; a single i.p.) shows anti-amnesic effects on Aβ 25-35-induced learning impairments in mice[1].
Fluoroethylnormemantine (0.1-10 mg/kg; i.p. once daily for 7 days) attenuates Aβ 25-35-induced behavioral deficits, neuroinflammation, oxidative stress, apoptosis, and cell loss in mice[1].
Fluoroethylnormemantine (1-20 mg/kg; a single injection) decreases behavioral despair in the forced swim test (FST) and reduces fear behavior in the cued fear conditioning (FC) and extinction training in rats[2].


Catalog Number I027446
CAS Number 1639210-25-5
Synonyms

3-(2-fluoroethyl)adamantan-1-amine;hydrochloride

Molecular Formula C12H21ClFN
Purity ≥95%
InChI InChI=1S/C12H20FN.ClH/c13-2-1-11-4-9-3-10(5-11)7-12(14,6-9)8-11;/h9-10H,1-8,14H2;1H
InChIKey KPURUIUXBWTRPB-UHFFFAOYSA-N
SMILES C1C2CC3(CC1CC(C2)(C3)N)CCF.Cl
Reference

[1]. Couly S, et, al. Anti-Amnesic and Neuroprotective Effects of Fluoroethylnormemantine in a Pharmacological Mouse Model of Alzheimer’s Disease. Int J Neuropsychopharmacol. 2021 Feb 15;24(2):142-157.
 [Content Brief]

[2]. Chen BK, et, al. Fluoroethylnormemantine, a novel derivative of memantine, facilitates extinction learning without sensorimotor deficits. Int J Neuropsychopharmacol. 2021 Feb 25;pyab007.
 [Content Brief]

[3]. Chen BK, et, al. Fluoroethylnormemantine, a novel NMDA receptor antagonist, for the prevention and treatment of stress-induced maladaptive behavior. Biological Psychiatry. 2021 May 9.

Request a Quote